The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy
- PMID: 1370506
- DOI: 10.1210/jcem.74.2.1370506
The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy
Abstract
The effects of a stable prostacyclin analog, Iloprost, and aldose reductase inhibitors (ONO-2235 and isoliquiritigenin) were studied to elucidate the role of cAMP in diabetic neuropathy in relation to polyol metabolism. In in vivo experiments, the cAMP and myoinositol contents in sciatic nerves and motor nerve conduction velocity were significantly reduced in diabetic rats. Iloprost significantly restored the reduced cAMP content in sciatic nerves and improved motor nerve conduction velocity in diabetic rats. However, the contents of sorbitol or myoinositol in sciatic nerves were not affected by Iloprost in diabetic rats. On the other hand, aldose reductase inhibitors significantly reduced the sorbitol content and increased the cAMP and myoinositol contents in the sciatic nerves of diabetic rats. The motor nerve conduction velocity was also slightly but significantly improved by treatment with aldose reductase inhibitors. There was a negative correlation between cAMP and sorbitol in the sciatic nerves of diabetic rats treated with aldose reductase inhibitors and a positive correlation between cAMP and motor nerve conduction velocity. In in vitro experiments, Iloprost significantly increased cAMP, but did not affect the sorbitol content in sciatic nerves. Aldose reductase inhibitors inhibited sorbitol accumulation and increased cAMP in sciatic nerves. Our data suggest that polyol pathway activation somehow results in cAMP reduction in sciatic nerves and that the reduction of cAMP in peripheral nerves may be closely related to the pathogenesis of diabetic neuropathy.
Similar articles
-
Epalrestat. A review of its pharmacology, and therapeutic potential in late-onset complications of diabetes mellitus.Drugs Aging. 1993 Nov-Dec;3(6):532-55. doi: 10.2165/00002512-199303060-00007. Drugs Aging. 1993. PMID: 8312678 Review.
-
Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.Diabetologia. 1997 Mar;40(3):271-81. doi: 10.1007/s001250050674. Diabetologia. 1997. PMID: 9084964
-
Cyclic adenosine 3',5'-monophosphate enhances sodium, potassium-adenosine triphosphatase activity in the sciatic nerve of streptozotocin-induced diabetic rats.Endocrinology. 1993 Feb;132(2):510-6. doi: 10.1210/endo.132.2.7678791. Endocrinology. 1993. PMID: 7678791
-
Continuous inhibition of excessive polyol pathway flux in peripheral nerves by aldose reductase inhibitor fidarestat leads to improvement of diabetic neuropathy.J Diabetes Complications. 1999 May-Jun;13(3):141-50. doi: 10.1016/s1056-8727(99)00038-0. J Diabetes Complications. 1999. PMID: 10509874
-
Sorbitol, myo-inositol and sodium-potassium ATPase in diabetic peripheral nerve.Drugs. 1986;32 Suppl 2:6-14. doi: 10.2165/00003495-198600322-00004. Drugs. 1986. PMID: 3024950 Review.
Cited by
-
An Integrative Pharmacology-Based Strategy to Uncover the Mechanism of Xiong-Pi-Fang in Treating Coronary Heart Disease with Depression.Front Pharmacol. 2021 Apr 1;12:590602. doi: 10.3389/fphar.2021.590602. eCollection 2021. Front Pharmacol. 2021. PMID: 33867976 Free PMC article.
-
Role of mitochondria in diabetic peripheral neuropathy: Influencing the NAD+-dependent SIRT1-PGC-1α-TFAM pathway.Int Rev Neurobiol. 2019;145:177-209. doi: 10.1016/bs.irn.2019.04.002. Epub 2019 Jun 8. Int Rev Neurobiol. 2019. PMID: 31208524 Free PMC article. Review.
-
The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat.J Clin Invest. 1994 Aug;94(2):853-9. doi: 10.1172/JCI117406. J Clin Invest. 1994. PMID: 8040341 Free PMC article.
-
Epalrestat. A review of its pharmacology, and therapeutic potential in late-onset complications of diabetes mellitus.Drugs Aging. 1993 Nov-Dec;3(6):532-55. doi: 10.2165/00002512-199303060-00007. Drugs Aging. 1993. PMID: 8312678 Review.
-
Effects of endothelin receptor antagonism with bosentan on peripheral nerve function in experimental diabetes.Br J Pharmacol. 1995 May;115(2):373-9. doi: 10.1111/j.1476-5381.1995.tb15888.x. Br J Pharmacol. 1995. PMID: 7670740 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical